Abstract
Clinical pharmacy services CPSs are still in their infancy in Yemen. Furthermore, pharmacists are not members of a multidisciplinary healthcare team, and their responsibilities are limited to drug dispensing and marketing. Thus, this study investigates physicians’ attitudes and perceived obstacles toward clinical pharmacists working in hospitals’ medical wards. A descriptive observational study was carried out using a validated self-administrated bilingual questionnaire. The study’s questionnaire was conducted among physicians in three teaching hospitals. Those hospitals were at the front to establish clinical pharmacy units and embrace clinical pharmacy services. Sixty-five responses were included. our data results indicated that physicians believed the most contributions for clinical pharmacists to improve patient care was “Attend medical rounds” 70.8%, followed by “Order review”. About 75% of physicians showed positive attitudes toward the clinical pharmacist role. However, more than 70% of physicians thought that clinical pharmacists should leave patient care to other healthcare members and care about drug products. There were Nine potential barriers out of 18 barriers were identified. Not enough clinical pharmacist staff working in the health center was considered as the top perceived barrier 83.1%; followed by clinical pharmacist responsibilities were not clearly defined”, and “clinical pharmacist recommendations are not properly documented”. In terms of enhancing physicians’ general attitudes and overcoming reported barriers. Strategies to expand clinical pharmacy services in Yemen should be emphasized on both, protocols should be established to outline how clinical pharmacists and physicians should collaborate besides, inter-professional collaboration relations are needed to be developed to overcome resistance and raise knowledge and awareness of CPS adoption among the healthcare team members.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NO
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants who took part in the study gave their verbal permission. The Deanship of College of Clinical Pharmacy at Hodeidah University, Al-Hudaydah, Yemen accepted the study's design and methodology in compliance with the Declaration of Helsinki with Reference No. (DM-2-1255).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
